This webinar focuses on ethical and policy challenges for performing xenotransplants under the U.S. Food and Drug Administration’s Expanded Access/Compassionate Use program. It explains how this program allows patients to get access to an investigational drug/biologic when certain conditions are met and describes the four xenotransplants that were performed under this program. The webinar also identifies ethical concerns about informed consent for patients obtaining a xenotransplant under the expanded access/compassionate pathway and describes ethical and policy implications of expanded access/compassionate use xenotransplants for first-in-human xenotransplant clinical trials.
Release Date: February 26, 2025
Language Availability: English
Suggested Audiences: Clinicians, Postdocs, Research Personnel, Researchers, Students
Organizational Subscription Price: Included as part of an annual subscription to our All Access Webinar Package
Independent Learner Price: $49 per person
